Skincare/Consumer Health Peptides

About Phenotypeca

Phenotypeca is a private, platform-based biotechnology company developing optimized yeast strains for recombinant protein manufacturing. Its patented QTL (Quantitative Trait Locus) strain optimization technology uses large-scale breeding and whole-genome screening to evolve strains with superior yield, stability, and processing characteristics. The company generates revenue by licensing ready-to-scale strains for biosimilars and peptides, and by providing custom strain engineering services to partners. It appears to be in an early-revenue stage, supported by project work including a grant from the Bill & Melinda Gates Foundation.

Therapeutic Areas